Ignite Creation Date:
2024-05-05 @ 9:53 AM
Last Modification Date:
2024-10-26 @ 9:05 AM
Study NCT ID:
NCT00005864
Status:
COMPLETED
Last Update Posted:
2013-01-31
First Post:
2000-06-02
Brief Title:
Chloroquinoxaline Sulfonamide in Treating Patients With Stage IV Colorectal Cancer
Sponsor:
Ohio State University Comprehensive Cancer Center
Organization:
National Cancer Institute NCI
Study Overview
Official Title:
A Phase II Study of Chloroquinoxaline Sulfonamide CQS in Colorectal Cancer Stage IV
Status:
COMPLETED
Status Verified Date:
2002-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
RATIONALE Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die
PURPOSE Phase II trial to study the effectiveness of chloroquinoxaline sulfonamide in treating patients who have stage IV colorectal cancer
PURPOSE Phase II trial to study the effectiveness of chloroquinoxaline sulfonamide in treating patients who have stage IV colorectal cancer
Detailed Description:
OBJECTIVES I Assess the antitumor activity and toxicities of chloroquinoxaline sulfonamide in patients with stage IV colorectal cancer
OUTLINE This is a multicenter study Patients receive chloroquinoxaline sulfonamide IV over 1 hour weekly for 4 consecutive weeks Treatment continues every 6 weeks in the absence of disease progression or unacceptable toxicity Patients are followed for at least 30 days
PROJECTED ACCRUAL A total of 16-25 patients will be accrued for this study within 8 months
OUTLINE This is a multicenter study Patients receive chloroquinoxaline sulfonamide IV over 1 hour weekly for 4 consecutive weeks Treatment continues every 6 weeks in the absence of disease progression or unacceptable toxicity Patients are followed for at least 30 days
PROJECTED ACCRUAL A total of 16-25 patients will be accrued for this study within 8 months
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| NCI-56 | None | None | None |
| OSU-NCI-56 | None | None | None |